- Nachrichtendetail
-
24.06.2024 13:57:55 - dpa-AFX: *BIOGEN'S TOFIDENCE BIOSIMILAR RECEIVES EC APPROVAL FOR MULTIPLE INDICATIONS INCL. COVID-19 TREATMENT
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Biogen | 789617 | NASDAQ | 211,890 | 30.07.24 22:00:10 | -2,540 | -1,18% | 211,890 | 217,100 | 214,290 | 214,430 |
